TrkB activation by 7, 8‐dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease
Authors:
- 29 December 2015
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 136 (3) , 620-636
Abstract
We recently demonstrated that activation of tyrosine receptor kinase B (TrkB) by 7, 8‐dihydroxyflavone (7, 8‐DHF), the selective TrkB agonist, increased surface alpha‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole‐propionic acid (AMPA) receptors (AMPARs) AMPA receptor subunit GluR1 (GluA1) subunit expression at the synapses of Fragile X Syndrome mutant mice. This present study investigated the effects of 7, 8‐DHF on both memory function and synapse structure in relation to the synapse protein level of AMPARs in the Tg2576 Alzheimer's disease (AD) mouse model. The study found that chronic oral administration of 7, 8‐DHF significantly improved spatial memory and minimized dendrite loss in the hippocampus of Tg2576 mice. A key feature of 7, 8‐DHF action was the increased expression of both GluA1 and GluA2 at synapses. Interestingly, 7, 8‐DHF had no effect on the attenuation of amyloid precursor protein or Aβ exhibiting in the Tg2576 AD brains, yet it activated the phosphorylation of TrkB receptors and its downstream signals including CaMKII, Akt, Erk1/2, and cAMP‐response element‐binding protein. Importantly, cyclotraxin B (a TrkB inhibitor), U0126 (a Ras‐ERK pathway inhibitor), Wortmannin (an Akt phosphorylation inhibitor), and KN‐93 (a CaMKII inhibitor) counteracted the enhanced expression and phosphorylation of AMPAR subunits induced by 7, 8‐DHF. Collectively, our results demonstrated that 7, 8‐DHF acted on TrkB and resolved learning and memory impairments in the absence of reduced amyloid in amyloid precursor protein transgenic mice partially through improved synaptic structure and enhanced synaptic AMPARs. The findings suggest that the application of 7, 8‐DHF may be a promising new approach to improve cognitive abilities in AD. image We provided extensive data demonstrating that 7, 8‐dihydroflavone, the TrkB agonist, improved Tg2576 mice spatial memory. This improvement is correlated with a reversion to normal values of GluA1 and GluA2 AMPA receptor subunits and dendritic spines in CA1. This work suggests that 7, 8‐DHF is a suitable drug to potentiate in vivo Tropomyosin receptor kinase B (TrkB) signaling in the Alzheimer's disease mice model.Keywords
Funding Information
- National Natural Science Foundation of China (31271199)
This publication has 73 references indexed in Scilit:
- Glucocorticoid receptors recruit the CaMKIIα-BDNF-CREB pathways to mediate memory consolidationNature Neuroscience, 2012
- BDNF increases with behavioral enrichment and an antioxidant diet in the aged dogNeurobiology of Aging, 2012
- Submicromolar Aβ42 reduces hippocampal glutamate receptors and presynaptic markers in an aggregation-dependent mannerBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- 7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, Reverses Memory Deficits and BACE1 Elevation in a Mouse Model of Alzheimer's DiseaseNeuropsychopharmacology, 2011
- A Synthetic 7,8-Dihydroxyflavone Derivative Promotes Neurogenesis and Exhibits Potent Antidepressant EffectJournal of Medicinal Chemistry, 2010
- BDNF-induced synaptic delivery of AMPAR subunits is differentially dependent on NMDA receptors and requires ERKNeurobiology of Learning and Memory, 2009
- Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's diseaseNature Medicine, 2009
- Coordinate action of pre- and postsynaptic brain-derived neurotrophic factor is required for AMPAR trafficking and acquisition of in vitro classical conditioningNeuroscience, 2008
- AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine LossNeuron, 2006
- Pathways towards and away from Alzheimer's diseaseNature, 2004